تولید مواد اولیه داروئی البرز بالک (سهامی خاص)
دبالک | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 17,000 0.70
Close Price: 16,900
Income Statement
AGM
Interim
2026/05/19 Fiscal Year 2025/12/2112 Month | 2025/05/25 Fiscal Year 2024/12/2012 Month | 2024/05/05 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 10.934 Trillion | 7.028 Trillion | 6.765 Trillion | |
Total Revenues | 10.934 Trillion | 7.028 Trillion | 6.765 Trillion | |
Cost of Goods Sold | 7.396 Trillion | 5.122 Trillion | 4.457 Trillion | |
Gross Profit | 3.537 Trillion | 1.906 Trillion | 2.308 Trillion | |
General & Administrative Expenses | 559.454 Billion | 389.308 Billion | 270.275 Billion | |
Net Operating Income & Expenses | -276.376 Billion | -139.266 Billion | -138.855 Billion | |
Operating Profit (Loss) | 2.702 Trillion | 1.377 Trillion | 1.899 Trillion | |
Profit Before Tax | 1.824 Trillion | 226.061 Billion | 1.156 Trillion | |
Tax | 323.946 Billion | 1.095 Billion | 228.667 Billion | |
Net Profit (Loss) After Tax | 1.501 Trillion | 224.966 Billion | 927.399 Billion | |
Retained Earnings at Beginning of Period | 473.963 Billion | 948.197 Billion | 726.697 Billion | |
Approved Dividends — Prior Year AGM | -23.66 Billion | -699.2 Billion | -515.9 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | - | -150 Billion | |
Allocable Profit | 1.951 Trillion | 473.963 Billion | 988.196 Billion | |
Legal Reserve | 75.028 Billion | - | 40 Billion | |
Approved Dividends — Current Year | 455 Billion | 23.66 Billion | 699.2 Billion | |
Retained Earnings at End of Period | 1.421 Trillion | 450.303 Billion | 248.996 Billion |